StockData
CervoMed Inc. logo

CervoMed Inc. (CRVO) stock

CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.45−0.05 (-3.33%)

Close on Nov 18, 2026Market cap $21.92MP/E –Yield –

CervoMed revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

CervoMed's revenue for the twelve months ending Jun 30, 2026 was $331.30K, down 95.7% year over year. For fiscal 2025 it was $4.01M, down 58.9% from the year before. The highest annual figure on record is $9.74M in fiscal 2024.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.01M-58.9%
FY2024Dec 31, 2024$9.74M+36.3%
FY2023Dec 31, 2023$7.14M–
FY2022Dec 31, 2022$0-100.0%
FY2013Dec 31, 2013$71.67K-80.9%
FY2012Dec 31, 2012$374.54K-34.3%
FY2011Dec 31, 2011$570.48K+1319.5%
FY2010Dec 31, 2010$40.19K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0-100.0%
Q1 FY2026Mar 31, 2026$0-100.0%
Q4 FY2025Dec 31, 2025$8.73K-99.6%
Q3 FY2025Sep 30, 2025$322.57K-83.4%
Q2 FY2025Jun 30, 2025$1.76M-46.6%
Q1 FY2025Mar 31, 2025$1.92M-18.3%
Q4 FY2024Dec 31, 2024$2.16M-13.2%
Q3 FY2024Sep 30, 2024$1.94M+27.1%
Q2 FY2024Jun 30, 2024$3.29M+91.2%
Q1 FY2024Mar 31, 2024$2.35M+66.7%
Q4 FY2023Dec 31, 2023$2.49M–
Q3 FY2023Sep 30, 2023$1.53M–
Q2 FY2023Jun 30, 2023$1.72M–
Q1 FY2023Mar 31, 2023$1.41M–
Q4 FY2022Dec 31, 2022$0–
Q3 FY2022Sep 30, 2022$0–

More CervoMed figures

See a number that looks wrong?